Mobile health services provider DocGo Inc. on Tuesday posted second-quarter 2026 earnings that fell short of analyst estimates, prompting a decline in its shares during after-hours trading.
The company reported adjusted earnings per share of 21 cents, below the 24-cent consensus forecast compiled by Refinitiv. Revenue totaled $295.3 million, also trailing the $302.1 million estimate.
DocGo attributed the shortfall to softer demand in certain service lines and higher operating costs. The company maintained its full-year 2026 guidance, reaffirming revenue guidance of $1.2 billion to $1.25 billion and adjusted EBITDA between $150 million and $165 million.
Shares of DocGo were down roughly 5% in extended trading following the release, reflecting investor disappointment over the quarterly performance despite the unchanged annual outlook.
Analysts at William Blair maintained a Market Perform rating on the stock, citing the near-term headwinds but acknowledging the company’s long-term growth trajectory in mobile health services.
DocGo’s mobile health units provide on-site and in-transit medical services, including ambulance transport and telehealth solutions, serving healthcare providers and insurers across the U.S. and internationally.
The company has expanded rapidly in recent years through acquisitions, positioning itself as a key player in the outsourced healthcare services sector.
Investor focus now shifts to the company’s ability to execute on its growth strategy amid margin pressures and competitive dynamics in the mobile health market.
